These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 465043)

  • 1. Absence of correlation between antiestrogenic activity and binding affinity for the estrogen receptor.
    Rochefort H; Garcia M; Borgna JL
    Biochem Biophys Res Commun; 1979 May; 88(2):351-7. PubMed ID: 465043
    [No Abstract]   [Full Text] [Related]  

  • 2. No loss of estrogenic or anti-estrogenic activity after demethylation of droloxifene (3-OH-tamoxifen).
    Löser R; Seibel K; Eppenberger U
    Int J Cancer; 1985 Dec; 36(6):701-3. PubMed ID: 4066073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogen basicity--activity relationships: a comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogues of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (tamoxifen, Nolvadex) having altered basicity.
    Robertson DW; Katzenellenbogen JA; Hayes JR; Katzenellenbogen BS
    J Med Chem; 1982 Feb; 25(2):167-71. PubMed ID: 7057423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen.
    Löser R; Seibel K; Roos W; Eppenberger U
    Eur J Cancer Clin Oncol; 1985 Aug; 21(8):985-90. PubMed ID: 4043181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of 4-methylestradiol.
    Qian XD; Abul-Hajj YJ
    J Steroid Biochem; 1990 May; 35(6):745-7. PubMed ID: 2362436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The agonistic and antagonistic properties of the high affinity antiestrogen--H1285.
    Ruh TS; Ruh MF
    Pharmacol Ther; 1983; 21(2):247-64. PubMed ID: 6312469
    [No Abstract]   [Full Text] [Related]  

  • 7. Binding and biological responses of antiestrogens in the fetal and newborn uteri of guinea-pig.
    Gulino A; Pasqualini JR
    J Steroid Biochem; 1981 Dec; 15():361-7. PubMed ID: 7339264
    [No Abstract]   [Full Text] [Related]  

  • 8. Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterus.
    Jordan VC; Gosden B
    Mol Cell Endocrinol; 1982 Aug; 27(3):291-306. PubMed ID: 7128917
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure-activity relationship of antiestrogens. Phenolic analogues of 2,3-diaryl-2H-1-benzopyrans.
    Sharma AP; Saeed A; Durani S; Kapil RS
    J Med Chem; 1990 Dec; 33(12):3222-9. PubMed ID: 2258908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivatives of tamoxifen. Dependence of antiestrogenicity on the 4-substituent.
    McCague R; Leclercq G; Legros N; Goodman J; Blackburn GM; Jarman M; Foster AB
    J Med Chem; 1989 Dec; 32(12):2527-33. PubMed ID: 2585441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immobilized antiestrogen binds a specific uterine protein in addition to estrogen receptor proteins.
    Van Oosbree TR; Olsen MR; Tate AC; Jordan VC; Mueller GC
    Mol Cell Endocrinol; 1984 May; 35(2-3):143-9. PubMed ID: 6734928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of antiestrogens and androgens on the estrogen receptor.
    Rochefort H; Capony F; Garcia M
    J Steroid Biochem; 1979; 11(5-6):1635-8. PubMed ID: 574911
    [No Abstract]   [Full Text] [Related]  

  • 13. Estrogen receptor-binding affinity of tamoxifen analogs with various side chains and their biologic profile in immature rat uterus.
    Agarwal AK; Bindal RD
    Steroids; 1991 Sep; 56(9):486-9. PubMed ID: 1805462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length.
    Hardcastle IR; Rowlands MG; Grimshaw RM; Houghton J; Jarman M
    J Med Chem; 1996 Feb; 39(4):999-1004. PubMed ID: 8632423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of LN 1643 (a triphenylbromoethylene antiestrogen): probable mediation by the estrogen receptor and high affinity metabolite.
    Borgna JL; Coezy E; Rochefort H
    Biochem Pharmacol; 1982 Oct; 31(20):3187-91. PubMed ID: 7150347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity.
    Jordan VC; Collins MM; Rowsby L; Prestwich G
    J Endocrinol; 1977 Nov; 75(2):305-16. PubMed ID: 591813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High affinity binding of the estrogen receptor to a DNA response element does not require homodimer formation or estrogen.
    Furlow JD; Murdoch FE; Gorski J
    J Biol Chem; 1993 Jun; 268(17):12519-25. PubMed ID: 8509392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogenic and antiestrogenic activity of monophenolic analogues of tamoxifen, (Z)-2-[p-(1,2-diphenyl-1-butenyl)phenoxy]-N, N-dimethylethylamine.
    Ruenitz PC; Bagley JR; Mokler CM
    J Med Chem; 1982 Sep; 25(9):1056-60. PubMed ID: 7131484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship of antiestrogens. Studies on 2,3-diaryl-1-benzopyrans.
    Saeed A; Sharma AP; Durani N; Jain R; Durani S; Kapil RS
    J Med Chem; 1990 Dec; 33(12):3210-6. PubMed ID: 2258906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.